Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-12

I doubt it. I have become extremely cynical to the point where I sold off everything after these results.

If you want an exercise of pain, go through the last 2 yrs of announced deals, including the answers in the Q&As and youll realise how little have come to fruition. Now its unreasonable to think all will go smoothly, but at some point its not bad luck that all the announcements prove to be worthless, and the market takes zero notice off the announced new deals. You can put lipstick on a pig, but its still a pig.

Its been an interesting painful ride with lots of learnings for me. I kept having faith over the last couple of years because at cashflow neutral I thought it gave the animal health and other more bespoke technologies a chance to mature and bring a new wave of success, but without a major overhaul in strategy (I only banged on about having a person on the board for the last yr that has experience in commercialising technology), and reducing expenditure my opinion is its doomed as an equity holder. A big decision needs to be made, do they consolidate or keep doubling down on this flogging off glorified sanitiser game and hope all these 'stockpiled' Zoono users are going to miraculously come calling for orders for the rest of 2022 to pay for the umpteen sales reps far and wide. If not, what's the plan? Capital raising will be super painful for any existing holder as new capital will cause a bucketload of dilution, assuming they can find someone thats happy to write a cheque. And, if the Zoono tech is a super power as portrayed, which IMO that likelihood is diminishing by the day, surely a chemical company would come and buy the joint out or atleast be actively looking whilst the share price is sunk.

Good luck to all holders. I wish you luck and hope the animal health segment comes good, as it would be great for the world. However, Im happy to waltz into the sunset and pursue other less stressful rides.